Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
62.78
+0.64 (1.03%)
At close: Nov 10, 2026, 4:00 PM EST
62.43
-0.36 (-0.57%)
After-hours: Nov 10, 2026, 7:30 PM EST

BMY Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
9,2437,054-8,9488,0256,3276,994
Depreciation & Amortization
2,0494,0779,5759,76910,28210,757
Loss (Gain) From Sale of Assets
-186-36-15-22-231-18
Asset Writedown & Restructuring Costs
4,4714,86316,4121,2109992,368
Loss (Gain) From Sale of Investments
-412-280-16160801-745
Stock-Based Compensation
552553507518457583
Other Operating Activities
-146-1,620-3,135-3,886-3,340-2,471
Change in Accounts Receivable
428-295264-995-663-1,054
Change in Inventory
182-184-486-751-6913
Change in Accounts Payable
542-2184198109245
Change in Income Taxes
-464-4-1,260-603-1,423-1,063
Change in Other Net Operating Assets
-5,607302,108237-183598
Operating Cash Flow
10,65214,15615,19013,86013,06616,207
Operating Cash Flow Growth
-35.91%-6.81%9.60%6.08%-19.38%15.34%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,366-1,311-1,248-1,209-1,118-973
Cash Acquisitions
-2,975-3,944-21,821-1,169-4,286-1,610
Divestitures
7911,0711,0999091,305748
Investment in Securities
-1,75752618-8263,0371,297
Investing Cash Flow
-5,307-4,132-21,352-2,295-1,062-538

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-253,086-194-
Long-Term Debt Issued
-5,74012,8834,4555,926-
Total Debt Issued
5,5245,76515,9694,4556,120-
Short-Term Debt Repaid
---3,000-120--160
Long-Term Debt Repaid
--10,940-2,873-3,879-11,431-6,022
Total Debt Repaid
-11,788-10,940-5,873-3,999-11,431-6,182
Net Debt Issued (Repaid)
-6,264-5,17510,096456-5,311-6,182
Issuance of Common Stock
---27984-
Repurchase of Common Stock
----5,155-8,001-6,287
Common Dividends Paid
-5,119-5,045-4,863-4,744-4,634-4,396
Other Financing Activities
-58-128-106--641
Financing Cash Flow
-11,441-10,3485,127-9,416-16,962-16,224

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-56195-13745-33-102
Net Cash Flow
-6,152-129-1,1722,194-4,991-657

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
9,28612,84513,94212,65111,94815,234
Free Cash Flow Growth
-39.31%-7.87%10.21%5.88%-21.57%14.55%
Free Cash Flow Margin
18.56%26.65%28.87%28.11%25.88%32.84%
Free Cash Flow Per Share
4.546.306.886.095.576.79
Levered Free Cash Flow
6,36511,14716,89013,60213,34112,786
Unlevered Free Cash Flow
7,39012,32918,11414,32714,09413,601

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,7002,1001,8001,2001,4001,500
Cash Income Tax Paid
4,0583,2643,9004,3005,4003,500
Change in Working Capital
-4,919-455810-1,914-2,229-1,261
SEC Filings: 10-K · 10-Q